Laboratorios Viñas, S.A.   Report issue

For profit Phase 4
Founded: Barcelona Spain (1911)
Status: No NME R&D (1911)

Organization Overview

First Clinical Trial
2016
NCT03000777
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Laboratorios Viñas, S.A.

Active Ingredients

Drugs in Phase 4 Trials (2)

melatonin (2 trials)

zn2+ (1 trial)

Drugs in Other Trials (3)

isomaltose (1 trial)

magnesium stearate (1 trial)

zinc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalomyelitis (Phase 4)

Fatigue (Phase 4)

Fatigue Syndrome, Chronic (Phase 4)

Myalgia (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5